MedPath

Monitoring HDR Brachytherapy for Cervical Cancer by Optic and Thermal Imaging

Not Applicable
Conditions
MALIGNANCY
Registration Number
NCT02818179
Lead Sponsor
Sheba Medical Center
Brief Summary

This research aims to investigate the correlation between tumor temperature difference and biological factors, such as size, metabolism, treatment response, and tumor aggressiveness.

In addition, normal tissue response to radiation therapy in treated organ will be evaluated.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • signed informed consent
  • biopsy proven cervical cancer which will undergo definitive radiation
Exclusion Criteria
  • not eligible to sign informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
The change in Infra-Red radiation emitted at wavelengths 0.8-1nmBaseline and 4 weeks

Measurement of IR

Secondary Outcome Measures
NameTimeMethod
Evaluating of efficacy of the radiation3 months after the treatment

The thermal and the optic imaging will be taken and analyzed in order to evaluate the changing in the temperature of the cervix comparing to the baseline as the indication of the response to the radiotherapy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.